[Why we recommend parenteral methotrexate for the treatment of rheumatoid arthritis: a response and overview of the literature]

Z Rheumatol. 2019 May;78(4):385-387. doi: 10.1007/s00393-019-0628-5.
[Article in German]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / administration & dosage
  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Humans
  • Infusions, Parenteral
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use*
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Methotrexate